What's happening in and around the Park? Here's an update from the team at the Illinois Science + Technology Park. | | Bisnow Features Life Science Real Estate | | |
On February 5th, Bisnow, ISTP, the Village of Skokie an others featured a lively discussion at the 8030 Lamon space.
Against the backdrop of historic investment and in the shadow of national competition, Bisnow convened leaders across quantum, biotechnology, life sciences, and real estate for discussions on the key trends, players, and projects shaping the region.
Attendees heard from developers, venture capitalists, scientists, and more in conversation on making Chicago and the broader Illinois region an open door for innovation and invention.
| | |
Topics addressed were:
Quantum Computing in the CRE Age - The strategic investments shaping the intersection of modern technology innovation and commercial real estate.
Life Sciences Innovations - People and projects striving to make Illinois a modern scientific hub, and the steps they’re taking to get it there.
An Exploration of the Region's Biotech Companies: How the relationship between lab space, engineering, and strategic investment is making Chicago the place to innovate in biotechnology.
Additionally, attendees learned about creating a capital stack for smart and forward-thinking investment and best practices for bringing new projects to fruition. Click to access program outline.
For more pictures, click here.
| | Cour and Roche: Autoimmune Deal | | |
Cour Pharmaceuticals is bringing its immunology mission to the fore with a new deal featuring Swiss drug juggernaut Roche. Roche’s Genentech unit has tapped Cour to help develop and commercialize the biotech’s bespoke tolerogenic nanoparticle treatments for autoimmune diseases.
Under the deal, Cour is in line to receive upfront and near-term milestones worth $40 million, plus add-on cashouts linked to development, commercial and net sales milestone payments in excess of $900 million in addition to tiered royalties on net sales.
Cour will handle preclinical development and manufacturing tech transfer as part of the agreement while Genentech is on deck to tackle clinical development, regulatory filings and marketing efforts.
| | |
““We see Genentech as an ideal partner with world-class scientific expertise and together have an opportunity to build upon Cour’s clinical success to date in autoimmune diseases,” Cour’s CEO, Dannielle Appelhans, said in a statement.
For more information, click here.
| | Renovation & Updates at 8045 Lamon | | |
The transformation of the ISTP campus draws inspiration from the fusion of science and nature, reinforcing the campus's commitment to wellness and sustainability. Updated common areas are designed to promote physical activity, social interaction, collaboration and a sense of connection in a dynamic scientific setting, marking a new chapter in the campus’s evolution.
The dramatic four-story atrium at the heart of the campus is anchored by a vertical volume of stacked meeting spaces clad in wood slats. Thoughtful lighting upgrades help define the architectural volume, while moveable furniture allows the large space to seamlessly transition from a third workplace to hosting informal gatherings and community events.
Hospitality-inspired areas for relaxation provide a comforting escape from structured lab environments. The redesign also extends to the auditorium and conference center, equipped with new technology, while refreshed locker rooms and restrooms feature spa-like amenities to further enrich the user experience.
Sustainability is a key focus of the design, with recycled content and carbon-neutral products prioritized in material selection. Biophilia-themed furnishings and finishes, along with carefully selected art pieces throughout the campus support the concept of scientific journey.
| | | V-OVS® next: Setting a New Standard for Luer Lock Syringe Closure Systems | | |
The V-OVS® system: A proven foundation for continuing innovation
Today’s closures typically need to meet a range of requirements to address the specific indications or markets they may be designed for: from essential protections for product integrity and security, to intuitive design and functionality, to detailed documentation.
The V-OVS® system has fulfilled these requirements for a wide range of Vetter customers who have adopted a Luer Lock system, providing strong differentiation, a premium look, and advanced functionality for products with many different indications. In the many years V-OVS® has been available, it has sustained high market acceptance, continuous volume uptake, and longstanding partnerships.
In the pharma market, though, it takes purposeful evolution to keep a step ahead. And that’s exactly what pharma companies can achieve with V-OVS® next
For more on the V-OVS® system, click here.
| | |
To develop V-OVS® next, Vetter followed a best-practice strategy with clearly defined requirements, a robust proof of concept, and rigorous user studies. Multiple key suppliers were also involved in the process, along with pharma customers and current V-OVS® users—all of whom offered valuable input on the usability, functionality, and processability parameters for the new design.
At the same time, Vetter also applied a new virtual concept testing approach that enabled Vetter to rapidly develop and evaluate many different iterations to identify an optimized design.
| | Illinois’ Capacity for Innovation & Economic Growth | | |
The Illinois Science and Technology Coalition (ISTC) recognizes research and development (R&D) as the cornerstone of innovation.
The Organisation for Economic Co-operation and Development (OECD) defines R&D as “creative work undertaken on a systematic basis to increase the stock of human knowledge, and the use of this knowledge to devise new applications.” Every dollar invested has the power to transform lives and economies—advancing cancer treatments, improving child safety in vehicles, and creating adaptable educational tools.
Illinois has a vibrant startup ecosystem ready to be leveraged by forward-thinking corporations. Venture Engine fills a critical gap in the state’s innovation ecosystem by creating new opportunities for startups, boosting innovation for our larger companies, and supporting equity as core to the mission. ISTC and World Business Chicago’s successful history of supporting startups, along with trusted partnerships within the state’s startup community, makes Venture Engine an impactful corporate-startup matchmaking tool for Illinois.
Click for more information.
| | |
Venture Engine connects Illinois’ most promising startups to the state’s most innovative corporations. Through its network of entrepreneurial support organizations (ESO’s), Venture Engine actively scouts and screens Illinois-based ventures that are corporate partnership-ready, and creates connections that lead to mutually beneficial collaboration. Venture Engine builds on nearly a decade of ISTC corporate-startup connectivity experience through its nationally award–winning Illinois Corporate-Startup Challenge.
| | Haffner Energy, LanzaJet, and LanzaTech Join Forces | | |
The three companies are exploring SAF production opportunities, including the development of commercial plants, joint technology licenses, and offtake opportunities as they become available, and funding support and/or investment in specific SAF projects.
“The three companies together demonstrate the type of partnership and technology alignment this industry will need to be successful in meeting the global demands of aviation,” says LanzaJet CEO Jimmy Samartzis. “CirculAir™, the joint product between LanzaJet and LanzaTech, brings together proprietary technologies to create low-carbon SAF from a variety of feedstocks, including discreet biomass sources. The technology developed by Haffner Energy further opens new opportunities for additional SAF production because it is biomass-agnostic.
“We are excited to team up with LanzaTech and LanzaJet to develop our first SAF projects together, says Haffner Energy co-founder and CEO Philippe Haffner. We’re confident that CirculAir™ is an exciting pathway, and we look forward to growing our global pipeline together thanks to our combined technologies."
| | |
Dr. Jennifer Holmgren, Chair and CEO of LanzaTech, and Board Chair of LanzaJet, stated,
“The powerful combination of CirculAir and Haffner Energy’s technologies widens the range of waste-based feedstocks able to be used to meet growing SAF demand. Together, our technologies and teaming can drive innovation and economic growth through advanced technology. This partnership is about more than just fuel production; it’s about creating well-paid jobs in rural areas, generating additional value from agricultural and forestry waste, and building new refineries that can bolster local economies."
To read the entire press release, click here.
| | |
Retiring Skokie Mayor George Van Dusen was recognized for his contributions. Van Dusen who has served on Skokie’s Village Board since 1984 and was appointed mayor in 1999 is ending a historical 40-year-run of leadership in Skokie.
In his 15 years as a trustee and 25 as mayor, Van Dusen served throughout Skokie’s police department accreditation, park district accreditation, the creation of an Oakton Street Yellow Line CTA “L” train station stop, redevelopment of Westfield Old Orchard Shopping Center, creation of the Illinois Science + Technology Park, launching of Backlot Bash, and countless other developments and accomplishments.
| | |
Mayor Daniel Biss of neighboring Evanston noted that Van Dusen is a “thoughtful, extremely pragmatic guy. Skokie is like his universe; he loves that town; he knows it like the back of his hand.”
| | Eight Healthy Resolutions for the New Year | |
- Get your blood pressure under control. Higher blood pressure increases the risk of heart attack and stroke.
- Keep cholesterol in check. High cholesterol can cause plaque buildup in the arteries and increase the risk of heart attack and stroke.
- Cut your sugar intake. High blood sugar ranges in those with prediabetes and diabetes can cause damage to many organs including the eyes, kidneys, nerves and heart.
- Get active every day. In addition to improving mood and helping with stress management, exercise can improve overall health and the above risk factors.
- Eat healthier food. A healthy diet heavy on fruits and vegetables helps you feel better and lose weight.
- Maintain a healthy weight. Being overweight puts extra physical stress on your body. If you're having trouble losing weight, Endeavor Health’s weight loss experts can help you achieve permanent weight loss and the healthy, active life you were meant to live.
- Stop smoking. Not only can smoking cigarettes lead to lung cancer, smoking also increases your risk of heart disease. Talk to your doctor about smoking cessation aids and resources to help you quit. Pick a quit date. Enlist the help of your family and friends.
- Get enough quality sleep. Adults generally need between 7-9 hours of sleep each night. Kids need more: 10-16 hours for ages 5 and younger (including naps); 9-12 hours for ages 6-12; and 8-10 hours for ages 13-18. Talk to your doctor if you or your child have trouble getting enough sleep.
| | |
Endeavor Health offers a full range of programs and services to help you reach your personal fitness and wellness goals. Even small changes in your lifestyle — exercising more and losing a few pounds — can improve your overall health.
If this seems like a tall order, consider this: These changes often have a domino effect. For instance, focusing on healthier eating and staying active will lead to weight loss. If you quit smoking, your blood pressure will improve.
Losing just 5 percent of your body weight can decrease blood sugar, blood pressure and cholesterol, and sometimes the reductions are enough to no longer need medications.
For more information, click here.
For health and wellness insights from Endeavor Health delivered right to your inbox, click here.
| | CASMI Wins 2024 Chicago Innovation Award | | |
UL Research Institutes–Northwestern University partnership recognized for advancing AI safety.
The Center for Advancing Safety of Machine Intelligence (CASMI) research hub, a partnership between UL Research Institutes and Northwestern University, has won a Chicago Innovation Award for its work to better incorporate safety into artificial intelligence.
The Materials Discovery Research Institute’s (MDRI) artificial intelligence-powered strategies for creating new materials to tackle climate change-related challenges are featured in a recent Chicago Tribune story.
Highlighting the institute’s goals to create new materials that will produce clean energy, water, and air, the Nov. 7 news story reports on the MDRI lab’s state-of-the-art equipment and automated processes. The story also covers how MDRI’s innovative lab aims to accelerate groundbreaking discovery.
CASMI has collaborated with ULRI’s Digital Safety Research Institute (DSRI) since February 2022 to establish a wide-ranging research network focused on creating the knowledge to develop artificial intelligence (AI) systems for safe and equitable use. As part of its mission, CASMI funds selected research projects across about 10 universities that focus on key AI challenges.
To read the entire announcement, click here..
| | G.D. Searle: North Shore Chicago Legacy | | |
The Illinois Science + Technology Park started with the former corporate headquarters of pharmaceutical giant G.D. Searle and has created a community of scientists, inventors, and innovators. We are dedicated to the cultivation of a multi-cultural environment that will create and sustain businesses from basic research through commercialization. This environment includes world class laboratories, office space and key support amenities.
Why Skokie? The company was located in the Ravenswood area of Chicago. The management was looking for a campus like setting where it could grow through out the second half of the 20th century. The decision to establish its operations in Skokie was driven by various strategic factors, including the area's favorable business environment, proximity to key markets, and access to skilled talent pool. This move not only enhanced the company's operational efficiency but also solidifies its position as a key player in the pharmaceutical industry. Learn more about ISTP.
| | Vetter: Product Innovation | | Illinois: Advancing Innovation | | | | |